Have a personal or library account? Click to login
Advanced Squamous Cell Carcinoma of the Skin Induced by Long-Term Hydroxyurea Treatment in a Patient with Essential Thrombocythemia Cover

Advanced Squamous Cell Carcinoma of the Skin Induced by Long-Term Hydroxyurea Treatment in a Patient with Essential Thrombocythemia

Acta Medica Bulgarica
Volume 51 (2024): Issue 2 (June 2024)
By: P. Vasilev,  M. Karaivanov,  D. Dimitrov,  P. Troyanova and  I. Yordanova  
Open Access
|Jun 2024

Authors

P. Vasilev

preslav.vasilev@abv.bg

Department of Dermatology, Venereology and Allergology, University Hospital “Dr. Georgi Stranski”, Faculty of Medicine, Medical University, Pleven

M. Karaivanov

Department of General and Clinical Pathology, University Hospital “Dr. Georgi Stranski”, Faculty of Medicine, Medical University, Pleven

D. Dimitrov

Surgical Oncology Department, University Hospital “Dr. Georgi Stranski”, Faculty of Medicine, Medical University, Pleven

P. Troyanova

Department of Nuclear Medicine, Radiation Therapy and Medical Oncology, University Hospital “Tsaritsa Yoanna”, Faculty of Medicine, Medical University, Sofia

I. Yordanova

Department of Dermatology, Venereology and Allergology, University Hospital “Dr. Georgi Stranski”, Faculty of Medicine, Medical University, Pleven
DOI: https://doi.org/10.2478/amb-2024-0019 | Journal eISSN: 2719-5384 | Journal ISSN: 0324-1750
Journal RSS Feed
Language: English
Page range: 49 - 52
Submitted on: Oct 11, 2023
|
Accepted on: Dec 12, 2023
|
Published on: Jun 23, 2024
Published by: Medical University - Sofia
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
squamous cell carcinoma of the skin,
essential thrombocythemia,
hydroxyurea,
cemiplimab
Related subjects:
Medicine,
Basic medical science,
Immunology,
Clinical medicine,
Clinical medicine, other

© 2024 P. Vasilev, M. Karaivanov, D. Dimitrov, P. Troyanova, I. Yordanova, published by Medical University - Sofia
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 51 (2024): Issue 2 (June 2024)Next article